etizolam has been researched along with gsk525762a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ajakane, M; Bamborough, P; Barnathan, M; Brusq, JM; Chung, CW; Clément, CA; Crowe, M; Cutler, L; Daugan, A; Gosmini, R; Grimes, RM; Haynes, AC; Jeffrey, P; Lewis, A; Mirguet, O; Mordaunt, JE; Nicodème, E; Parr, N; Pineau, O; Prinjha, RK; Smithers, NN; Toum, J; Uings, IJ; Witherington, J | 1 |
1 other study(ies) available for etizolam and gsk525762a
Article | Year |
---|---|
Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Apolipoprotein A-I; Benzodiazepines; Cell Cycle Proteins; Dogs; Epigenesis, Genetic; Humans; Macaca fascicularis; Mice; Models, Molecular; Nuclear Proteins; Permeability; Protein Structure, Tertiary; Rats; Stereoisomerism; Structure-Activity Relationship; Transcription Factors | 2013 |